Pharmaceutical Plant Protein Market 2027 By Source, Disease Indication, Distribution Channel and Geography | The Insight Partners

Pharmaceutical Plant Protein Market to 2027 - Global Analysis and Forecasts By Source (Soy, Pea, Wheat, and Other Sources); Disease Indication (Genetic Disorders, Cancer, Virus Diseases, and Other Disease Indications); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography

Report Code: TIPRE00008686 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Proteins obtained for plant origin for the production of pharmaceutical products both for therapeutic and diagnostic purposes have received significant recognition during the recent years. Utilizing plant proteins in the pharmaceutical industry comes along with various benefits such as lower costs compared to the traditional methods, which are based on microbial fermentation, mammalian, and insect cell cultures.

MARKET DYNAMICS

The pharmaceutical plant protein market is anticipated to grow in the forecast, owing to the rising need for a novel therapeutic approach for the treatment of various medical conditions. Also, the rise in R&D expenditures made by the manufacturers for the introduction of new drugs is considered to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Pharmaceutical Plant Protein Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the pharmaceutical plant protein market with detailed market segmentation by source, disease indication, and geography. The pharmaceutical plant protein market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pharmaceutical plant protein market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pharmaceutical plant protein market is segmented based on source and disease indication. Based on the source, the market is segmented as soy, pea, wheat, and other sources. Based on the disease indication, the market is classified as genetic disorders, cancer, virus diseases, and other disease indications. Similarly, based on the configuration channel, the market is categorized as, hospital pharmacies and retail pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pharmaceutical plant protein market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pharmaceutical plant protein market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pharmaceutical plant protein market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pharmaceutical plant protein market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pharmaceutical plant protein market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pharmaceutical plant protein market are anticipated to have lucrative growth opportunities in the future with the rising demand for pharmaceutical plant protein market in the global market. Below mentioned is the list of few companies engaged in the pharmaceutical plant protein market.

The report also includes the profiles of key pharmaceutical plant protein market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Axiom Foods, Inc.
- Duynie Group
- Greenovation Biotech GmbH
- iBio
- Icon Genetics GmbH
- PlantForm
- Protalix Biotherapeutics
- Ventria Bioscience Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Plant Protein Market - By Source
1.3.2 Pharmaceutical Plant Protein Market - By Disease Indication
1.3.3 Pharmaceutical Plant Protein Market - By Distribution Channel
1.3.4 Pharmaceutical Plant Protein Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PHARMACEUTICAL PLANT PROTEIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PHARMACEUTICAL PLANT PROTEIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PHARMACEUTICAL PLANT PROTEIN MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL PLANT PROTEIN - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL PLANT PROTEIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PHARMACEUTICAL PLANT PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - SOURCE
7.1. OVERVIEW
7.2. SOURCE MARKET FORECASTS AND ANALYSIS
7.3. SOY
7.3.1. Overview
7.3.2. Soy Market Forecast and Analysis
7.4. PEA
7.4.1. Overview
7.4.2. Pea Market Forecast and Analysis
7.5. WHEAT
7.5.1. Overview
7.5.2. Wheat Market Forecast and Analysis
7.6. OTHER SOURCES
7.6.1. Overview
7.6.2. Other Sources Market Forecast and Analysis
8. PHARMACEUTICAL PLANT PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. GENETIC DISORDERS
8.3.1. Overview
8.3.2. Genetic Disorders Market Forecast and Analysis
8.4. CANCER
8.4.1. Overview
8.4.2. Cancer Market Forecast and Analysis
8.5. VIRUS DISEASES
8.5.1. Overview
8.5.2. Virus Diseases Market Forecast and Analysis
8.6. OTHER DISEASE INDICATIONS
8.6.1. Overview
8.6.2. Other Disease Indications Market Forecast and Analysis
9. PHARMACEUTICAL PLANT PROTEIN MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
10. PHARMACEUTICAL PLANT PROTEIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pharmaceutical Plant Protein Market Overview
10.1.2 North America Pharmaceutical Plant Protein Market Forecasts and Analysis
10.1.3 North America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Source
10.1.4 North America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pharmaceutical Plant Protein Market
10.1.6.1.1 United States Pharmaceutical Plant Protein Market by Source
10.1.6.1.2 United States Pharmaceutical Plant Protein Market by Disease Indication
10.1.6.1.3 United States Pharmaceutical Plant Protein Market by Distribution Channel
10.1.6.2 Canada Pharmaceutical Plant Protein Market
10.1.6.2.1 Canada Pharmaceutical Plant Protein Market by Source
10.1.6.2.2 Canada Pharmaceutical Plant Protein Market by Disease Indication
10.1.6.2.3 Canada Pharmaceutical Plant Protein Market by Distribution Channel
10.1.6.3 Mexico Pharmaceutical Plant Protein Market
10.1.6.3.1 Mexico Pharmaceutical Plant Protein Market by Source
10.1.6.3.2 Mexico Pharmaceutical Plant Protein Market by Disease Indication
10.1.6.3.3 Mexico Pharmaceutical Plant Protein Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pharmaceutical Plant Protein Market Overview
10.2.2 Europe Pharmaceutical Plant Protein Market Forecasts and Analysis
10.2.3 Europe Pharmaceutical Plant Protein Market Forecasts and Analysis - By Source
10.2.4 Europe Pharmaceutical Plant Protein Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Pharmaceutical Plant Protein Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pharmaceutical Plant Protein Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pharmaceutical Plant Protein Market
10.2.6.1.1 Germany Pharmaceutical Plant Protein Market by Source
10.2.6.1.2 Germany Pharmaceutical Plant Protein Market by Disease Indication
10.2.6.1.3 Germany Pharmaceutical Plant Protein Market by Distribution Channel
10.2.6.2 France Pharmaceutical Plant Protein Market
10.2.6.2.1 France Pharmaceutical Plant Protein Market by Source
10.2.6.2.2 France Pharmaceutical Plant Protein Market by Disease Indication
10.2.6.2.3 France Pharmaceutical Plant Protein Market by Distribution Channel
10.2.6.3 Italy Pharmaceutical Plant Protein Market
10.2.6.3.1 Italy Pharmaceutical Plant Protein Market by Source
10.2.6.3.2 Italy Pharmaceutical Plant Protein Market by Disease Indication
10.2.6.3.3 Italy Pharmaceutical Plant Protein Market by Distribution Channel
10.2.6.4 Spain Pharmaceutical Plant Protein Market
10.2.6.4.1 Spain Pharmaceutical Plant Protein Market by Source
10.2.6.4.2 Spain Pharmaceutical Plant Protein Market by Disease Indication
10.2.6.4.3 Spain Pharmaceutical Plant Protein Market by Distribution Channel
10.2.6.5 United Kingdom Pharmaceutical Plant Protein Market
10.2.6.5.1 United Kingdom Pharmaceutical Plant Protein Market by Source
10.2.6.5.2 United Kingdom Pharmaceutical Plant Protein Market by Disease Indication
10.2.6.5.3 United Kingdom Pharmaceutical Plant Protein Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pharmaceutical Plant Protein Market Overview
10.3.2 Asia-Pacific Pharmaceutical Plant Protein Market Forecasts and Analysis
10.3.3 Asia-Pacific Pharmaceutical Plant Protein Market Forecasts and Analysis - By Source
10.3.4 Asia-Pacific Pharmaceutical Plant Protein Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Pharmaceutical Plant Protein Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pharmaceutical Plant Protein Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pharmaceutical Plant Protein Market
10.3.6.1.1 Australia Pharmaceutical Plant Protein Market by Source
10.3.6.1.2 Australia Pharmaceutical Plant Protein Market by Disease Indication
10.3.6.1.3 Australia Pharmaceutical Plant Protein Market by Distribution Channel
10.3.6.2 China Pharmaceutical Plant Protein Market
10.3.6.2.1 China Pharmaceutical Plant Protein Market by Source
10.3.6.2.2 China Pharmaceutical Plant Protein Market by Disease Indication
10.3.6.2.3 China Pharmaceutical Plant Protein Market by Distribution Channel
10.3.6.3 India Pharmaceutical Plant Protein Market
10.3.6.3.1 India Pharmaceutical Plant Protein Market by Source
10.3.6.3.2 India Pharmaceutical Plant Protein Market by Disease Indication
10.3.6.3.3 India Pharmaceutical Plant Protein Market by Distribution Channel
10.3.6.4 Japan Pharmaceutical Plant Protein Market
10.3.6.4.1 Japan Pharmaceutical Plant Protein Market by Source
10.3.6.4.2 Japan Pharmaceutical Plant Protein Market by Disease Indication
10.3.6.4.3 Japan Pharmaceutical Plant Protein Market by Distribution Channel
10.3.6.5 South Korea Pharmaceutical Plant Protein Market
10.3.6.5.1 South Korea Pharmaceutical Plant Protein Market by Source
10.3.6.5.2 South Korea Pharmaceutical Plant Protein Market by Disease Indication
10.3.6.5.3 South Korea Pharmaceutical Plant Protein Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pharmaceutical Plant Protein Market Overview
10.4.2 Middle East and Africa Pharmaceutical Plant Protein Market Forecasts and Analysis
10.4.3 Middle East and Africa Pharmaceutical Plant Protein Market Forecasts and Analysis - By Source
10.4.4 Middle East and Africa Pharmaceutical Plant Protein Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Pharmaceutical Plant Protein Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pharmaceutical Plant Protein Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pharmaceutical Plant Protein Market
10.4.6.1.1 South Africa Pharmaceutical Plant Protein Market by Source
10.4.6.1.2 South Africa Pharmaceutical Plant Protein Market by Disease Indication
10.4.6.1.3 South Africa Pharmaceutical Plant Protein Market by Distribution Channel
10.4.6.2 Saudi Arabia Pharmaceutical Plant Protein Market
10.4.6.2.1 Saudi Arabia Pharmaceutical Plant Protein Market by Source
10.4.6.2.2 Saudi Arabia Pharmaceutical Plant Protein Market by Disease Indication
10.4.6.2.3 Saudi Arabia Pharmaceutical Plant Protein Market by Distribution Channel
10.4.6.3 U.A.E Pharmaceutical Plant Protein Market
10.4.6.3.1 U.A.E Pharmaceutical Plant Protein Market by Source
10.4.6.3.2 U.A.E Pharmaceutical Plant Protein Market by Disease Indication
10.4.6.3.3 U.A.E Pharmaceutical Plant Protein Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pharmaceutical Plant Protein Market Overview
10.5.2 South and Central America Pharmaceutical Plant Protein Market Forecasts and Analysis
10.5.3 South and Central America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Source
10.5.4 South and Central America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pharmaceutical Plant Protein Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pharmaceutical Plant Protein Market
10.5.6.1.1 Brazil Pharmaceutical Plant Protein Market by Source
10.5.6.1.2 Brazil Pharmaceutical Plant Protein Market by Disease Indication
10.5.6.1.3 Brazil Pharmaceutical Plant Protein Market by Distribution Channel
10.5.6.2 Argentina Pharmaceutical Plant Protein Market
10.5.6.2.1 Argentina Pharmaceutical Plant Protein Market by Source
10.5.6.2.2 Argentina Pharmaceutical Plant Protein Market by Disease Indication
10.5.6.2.3 Argentina Pharmaceutical Plant Protein Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PHARMACEUTICAL PLANT PROTEIN MARKET, KEY COMPANY PROFILES
12.1. AXIOM FOODS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DUYNIE GROUP
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GREENOVATION BIOTECH GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IBIO
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ICON GENETICS GMBH
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PLANTFORM
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PROTALIX BIOTHERAPEUTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. VENTRIA BIOSCIENCE INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Axiom Foods, Inc.
2. Duynie Group
3. Greenovation Biotech GmbH
4. iBio
5. Icon Genetics GmbH
6. PlantForm
7. Protalix Biotherapeutics
8. Ventria Bioscience Inc.
TIPRE00008686
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking